aDobney Hypertension Centre, Medical School – Royal Perth Hospital Unit/Royal Perth Hospital Research Foundation, University of Western Australia, Perth, Western Australia
bDepartment of Medicine, Endocrine Hypertension Group, Hudson Institute of Medical Research
cHypertension Research Laboratory, School of Biological Sciences, Monash University
dHeart Failure Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria
eMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania
fIverson Health Innovation Research Institute, Swinburne University of Technology, Melbourne, Victoria, Australia
gDepartment of Primary Care and Public Health
hImperial Clinical Trials Unit, Imperial College London, London, UK
iSchool of Population Health, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales
jSchool of Population Health, Centre of Clinical Research and Education, Curtin University, Bentley
kDepartments of Cardiology and Nephrology, Royal Perth Hospital, Perth, Western Australia, Australia
Correspondence to Markus P. Schlaich, Dobney Chair in Clinical Research, Medical School – Royal Perth Hospital Unit/Royal Perth Hospital Research Foundation, The University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth 6000, WA, Australia. Tel: +61 8 9224 0382; fax: +61 8 9224 0374; e-mail: [email protected]
Abbreviations: ABS, Australian Bureau of Statistics; AUD, Australian dollar; BP, blood pressure; MMM, May Measurement Month
Received 23 July, 2022
Revised 10 December, 2022
Accepted 6 January, 2023
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).
